Our subsequent experiments revealed that STOML2 triggers the upregulation of PD-L1 expression level and mediates the tumor immune escape indicating that STOML2 contributed to CRC progression via promoting the concurrent of angiogenesis and immunosuppression. This evidence concerns the gene CD274 and colorectal carcinoma.